Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Future NDAC meetings

This article was originally published in The Tan Sheet

Executive Summary

Future NDAC meetings: On Jan. 22, the Nonprescription and Anti-infective Drugs Advisory Committees will jointly meet to discuss an antimicrobial health care continuum model, FDA said. The Cosmetic, Toiletry & Fragrance Association and the Soap & Detergent Association will make a joint presentation on the model at the meeting. CTFA and SDA proposed the HCCM to expand FDA's health care antiseptic categories, outlined in the June 1994 tentative final monograph on topical antiseptic drug products, to include general-use handwash, general-use bodywash and food handlers' handwash categories. Also, NDAC will meet jointly with the Cardio-Renal Drugs Advisory Committee on Jan. 23 to discuss professional labeling for indications for aspirin. The meetings will be held at the Gaithersburg Holiday Inn, beginning at 8:30 a.m. both days...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel